How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care

Host: Jacob Sands, MD Guest: Nabil F. Saba, MD, FACP Since head and neck cancer is still to a large extent a surgical disease, the COVID-19 pandemic had an immediate impact on its management. Here to share how he pivoted his approach and how the pandemic might impact the future of head and neck cancer care is Dr. Nabil Saba, a Professor and Vice Chair for Quality and Safety in the Department of Hematology and Medical Oncology at the Emory University School of Medicine.